August 28, 2016 1:58 PM ET

Biotechnology

Company Overview of Eureka Therapeutics, Inc.

Executive Profile

Chih-Kai Cheng MBA

AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background

Mr. C. K. Cheng is the Co-founder and General Partner of Harbinger III Venture Capital, a pan-Pacific venture capital firm actively investing in US, Taiwan, and China. Prior to founding Harbinger III Venture Capital in 2000 with the anchor investment from MiTAC/Synnex Group, Mr. Cheng served as Senior Vice President of Product Marketing at Synnex (NYSE:SNX). During his 8-year tenure with Synnex, he held various management responsibilities including product line management, ...

Corporate Headquarters

5858 Horton Street
Emeryville, California 94608

United States

Phone: 510-654-7045
Fax: 510-654-7077

Board Members Memberships

Director

Education

MBA
National Chiao Tung University
BS
National Tsing-hua University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Eureka Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.